CEP55 and pancreatic adenocarcinoma: Collectively, seven tumors (KIRC, KIRP, PAAD, ACC, LGG, LIHC, and MESO) experienced a positive correlation between CEP55 and the patients’ survival under both of the studied modules, a finding that supports the reliance on CEP55 as a potential prognosis biomarker.